1-5 of 5
Colleen Timlin, PharmD, BCOP
Close
Sort by
Journal Articles

Real-World Evidence for Durable Treatment Responses after Toxicity Related Discontinuation of Idelalisib

Erin Bange, MD, Chadi Nabhan, MD MBA, FACP, Danielle M. Brander, MD, Nicole Lamanna, MD, Chaitra S. Ujjani, MD, Christina Howlett, PharmD, BCOP, Alan P Skarbnik, MD, Brian T. Hill, MD PhD, Bruce D. Cheson, MD, Clive S Zent, MD, Jeffrey J. Pu, MD PhD, Allison M. Winter, MD, Krista Isaac, DO, MS, Kaitlin Kennard, RN, BSN, Colleen Timlin, PharmD, BCOP, Colleen Dorsey, BSN, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Daniel J. Landsburg, MD, Stephen J. Schuster, MD, Paul M. Barr, MD, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4325.
https://doi.org/10.1182/blood.V130.Suppl_1.4325.4325
Published: 2017
Journal Articles

Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas

Mitchell E. Hughes, PharmD, BCPS, BCOP, Christopher Jensen, MD, Jakub Svoboda, MD, Lauren Elizabeth Strelec, BA, Matthew R. Youngman, BS, Stephen J. Schuster, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Donald Edward Tsai, MD PhD, David Michael Mintzer, MD, Jennifer Gill, NP, MSN, Colleen Dorsey, BSN, Kaitlin Kennard, RN, BSN, Elizabeth T Chatburn, BS, Joanna Rhodes, MD, Krista Isaac, DO, MS, Kristy Walsh, BS, Tanya Latorre, BSN, RN, Kaley Piersanti, BS, Evan Bannister, BS, Colleen Timlin, PharmD, BCOP, Donna Capozzi, PharmD, BCOP, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1575.
https://doi.org/10.1182/blood.V130.Suppl_1.1575.1575
Published: 2017
Journal Articles

Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract

Alex Ganetsky, PharmD, BCOP, Noelle V Frey, MD, Alison W Loren, MD MS, Elizabeth O. Hexner, MD, James K Mangan, MD PhD, Saar I Gill, MBBS, PhD, Selina Luger, MD, Adam D. Cohen, MD, Daria V Babushok, MDPhD, Edward A Stadtmauer, MD, Jacqueline Smith, CRNP, William R. Drobyski, MD, Sarah K Kraus, PharmD, Colleen Timlin, PharmD, BCOP, David L. Porter, MD
Journal: Blood
Blood (2016) 128 (22): 2245.
https://doi.org/10.1182/blood.V128.22.2245.2245
Published: 2016
Journal Articles

A Comparison of Single Dose Rasburicase 3 Mg Versus 6 Mg for the Management of Tumor Lysis Syndrome

Sarah K Kraus, PharmD, Catherine E Burdalski, PharmD, Colleen Timlin, PharmD, BCOP, Tracy M Krause, PharmD, BCOP, Todd A Miano, PharmD, MSCE, Jakub Svoboda, MD, Alex Ganetsky, PharmD, BCOP
Journal: Blood
Blood (2015) 126 (23): 4511.
https://doi.org/10.1182/blood.V126.23.4511.4511
Published: 2015
Journal Articles

Outcome of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Cytarabine Monotherapy

Jonathan Canaani, MD, Marlise R. Luskin, MD, Alison Loren, MD MS, Colleen Timlin, PharmD, BCOP, James Mangan, MD PhD, Elizabeth O. Hexner, MD, Noelle V. Frey, MDMS, David L Porter, MD, Edward A. Stadtmauer, MD, Selina Luger, MD
Journal: Blood
Blood (2015) 126 (23): 2543.
https://doi.org/10.1182/blood.V126.23.2543.2543
Published: 2015